Logo

PerkinElmer to Use Orchid Tech to Develop, Sell SNP-Diagnostic Assays

Jul 09, 2002

NEW YORK, July 9 - PerkinElmer will develop and sell fluorescence-based SNP-diagnostic assays gleaned from genotyping technology owned by Orchid Bioscience, the companies said today.

 

By taking this step, PerkinElmer cashes in an option granted by Orchid to obtain exclusive rights to its SNP-IT technology in fluorescence polarization-based reagent kits.

That agreement, struck in December 2000, gave PerkinElmer exclusive rights to sell to the products market tools based on the Orchid technology. The latest option allows PerkinElmer to concentrate on the molecular-diagnostics market, the firms said.

 

Click here for more information.

Breaking News
The Scan

Interfering With Invasive Mussels

The Chicago Tribune reports that researchers are studying whether RNA interference- or CRISPR-based approaches can combat invasive freshwater mussels.

Participation Analysis

A new study finds that women tend to participate less at scientific meetings but that some changes can lead to increased involvement, the Guardian reports.

Right Whales' Decline

A research study plans to use genetic analysis to gain insight into population decline among North American right whales, according to CBC.

Science Papers Tie Rare Mutations to Short Stature, Immunodeficiency; Present Single-Cell Transcriptomics Map

In Science this week: pair of mutations in one gene uncovered in brothers with short stature and immunodeficiency, and more.